πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 15 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12201639

Aqueous oral pharmaceutical suspension compositions

ReveraGen BioPharma, Inc. Β· Granted Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11833159

Non-hormonal steroid modulators of NF-kB for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11690853

Non-hormonal steroid modulators of NF-ΞΊΞ² for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11471471

Aqueous oral pharmaceutical suspension compositions

ReveraGen BioPharma, Inc. Β· Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11382922

Aqueous oral pharmaceutical suspension compositions

ReveraGen BioPharma, Inc. Β· Granted Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10857161

Non-hormonal steroid modulators of NF-kB for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10799514

Non-hormonal steroid modulators of NF-kappa beta for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10464967

Non-hormonal steroid modulators of NF-ΞΊΞ² for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10206933

Non-hormonal steroid modulators of NF-kB for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10000525

Non-hormonal steroid modulators of NF-ΞΊB for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9649320

Non-hormonal steroid modulators of NF-ΞΊB for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9637738

Methods and agents to increase therapeutic dystrophin expression in muscle

ReveraGen BioPharma, Inc. Β· Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9434758

Non-hormonal steroid modulators of NF-ΞΊB for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9198921

Non-hormonal steroid modulators of NF-ΞΊB for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673887

Non-hormonal steroid modulators of NF-kB for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted